Neuroprotective effects of MK-801 and catecholamine release in the central nervous system.
Tsuda
Kazushi
K
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D002539:Cerebral Arterial Diseases / Q000517:prevention & control*; D004195:Disease Models, Animal; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D005971:Glutamates / Q000378:metabolism / Q000502:physiology; D006801:Humans; D020768:Middle Cerebral Artery / Q000187:drug effects / Q000503:physiopathology; D008959:Models, Neurological; D018696:Neuroprotective Agents / Q000494:pharmacology*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D020521:Stroke / Q000503:physiopathology / Q000517:prevention & control*
D002395:Catecholamines; D005971:Glutamates; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D016291:Dizocilpine Maleate